Cisplatin, Methotrexate and Mitoxantrone in Patients with Metastatic or Advanced Urothelial Cancer

Authors

  • Lisbeth J. Andersen From the Department of Oncology, Aarhus University Hospital, Aarhus (L. J. Andersen, H. von der Maase), and the Department of Oncology, Herlev University Hospital, Herlev (L. Sengelov, C. Kamby), Denmark
  • Lisa Sengeløv From the Department of Oncology, Aarhus University Hospital, Aarhus (L. J. Andersen, H. von der Maase), and the Department of Oncology, Herlev University Hospital, Herlev (L. Sengelov, C. Kamby), Denmark
  • Claus Kamby From the Department of Oncology, Aarhus University Hospital, Aarhus (L. J. Andersen, H. von der Maase), and the Department of Oncology, Herlev University Hospital, Herlev (L. Sengelov, C. Kamby), Denmark
  • Hans von der Maase From the Department of Oncology, Aarhus University Hospital, Aarhus (L. J. Andersen, H. von der Maase), and the Department of Oncology, Herlev University Hospital, Herlev (L. Sengelov, C. Kamby), Denmark

DOI:

https://doi.org/10.1080/028418698423276

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

1998-01-01

How to Cite

Andersen, L. J. ., Sengeløv, L. ., Kamby, C. ., & Maase, H. von der . (1998). Cisplatin, Methotrexate and Mitoxantrone in Patients with Metastatic or Advanced Urothelial Cancer. Acta Oncologica, 37(1), 110–112. https://doi.org/10.1080/028418698423276

Issue

Vol. 37 No. 1 (1998): Acta Oncologica

Section

Articles